Full course description
The KIND Communication Disorders Chapter provides a thorough exploration of communication disorders, addressing foundational topics such as normal language development and epidemiology, and advancing through specific disorders like speech sound and fluency issues. Key topics include red flags for language disorders, bilingual assessment considerations, and strategies for optimizing language development. Tailored for allied and medical professionals, the course emphasizes practical application, culminating in an interactive case scenario that allows learners to apply their skills in assessing and managing communication disorders in real-world settings.
The Communication Disorders Chapter spans 20 topics across five levels of instruction. Levels 1 and 2 provide foundational knowledge beneficial for medical professionals and allied professionals, including educators, social workers, therapists, and psychologists. Levels 3 to 5 shift to a more clinical focus, offering advanced insights geared toward medical doctors and sub-specialists.
The table below outlines the complete chapter content.
Chapter Editor
Dr. Mary L. O'Connor Leppert, MD, BCh is a neurodevelopmental pediatrician in the Department of Neurology and Developmental Medicine at Kennedy Krieger Institute. Dr. Leppert is also the Division Director of Developmental Pediatrics in the Department of Pediatrics at Johns Hopkins University School of Medicine. Dr. Leppert's focus is on the education on neurodevelopmental disorders. She is the founder and director of the Teaching Excellence in Neuro Development (TEND) program, the director of Kennedy Krieger Project ECHO and is the chief editor of the Kennedy Krieger Instruction in Neurodevelopmental Disorders (KIND) curriculum. In addition, Dr. Leppert is an associate professor of pediatrics at the Johns Hopkins University School of Medicine.
Content, Featured Experts, and Learner Groups
Level |
Neurodevelopmental Topic Content |
Featured Expert |
Learner Group(s) |
Level 1 |
1.1 Communication Disorders and Vocabulary |
Mary Leppert, MB, BCH |
Allied professionals Medical Professionals Sub-Specialist Professionals |
1.2 Epidemiology of Communication Disorders |
Mary Leppert, MB, BCH |
||
1.3 Normal Language Development |
Mihee Bay, MD |
||
Level 2 |
2.1 Red Flags for Language Disorders |
Mihee Bay, MD |
Allied professionals Medical Professionals Sub-Specialist Professionals |
2.2 Speech Sound Disorders Defined |
Wendy A. Jennejahn, M.S., CCC-SLP |
||
2.3 Mixed Receptive and Expressive Disorders |
Mary Leppert, MB BCH |
||
2.4 Expressive Language Disorders |
Mary Leppert, MB BCH |
||
2.5 Social Pragmatic Communication Disorder Defined |
Kate Smidl, MS, CCC-SLP |
||
2.6 Fluency Disorders Defined |
Kate Smidl, MS, CCC-SLP |
||
Level 3 |
3.1 Considerations in Taking a History of Language Impairment |
Mary Leppert, MB BCH |
Medical Professionals Sub-Specialist Professionals |
3.2 Oral Motor Evaluation in a Child with Speech Sound Disorder |
Wendy A. Jennejahn, M.S., CCC-SLP |
||
3.3 Office Assessment of Speech and Language |
Mary Leppert, MB BCH |
||
3.4 Language Assessment Considerations in Simultaneously Bilingual Children |
Amber Surveski, MS, CCC-SLP |
||
3.5 Speech and Language Pathology Assessment Measures |
Kate Smidl, MS, CCC-SLP |
||
3.6 Social Pragmatic Language Assessment |
Kate Smidl, MS, CCC-SLP |
||
Level 4 |
4.1 Optimizing Language Development |
Mary Leppert, MB BCH |
Medical Professionals Sub-Specialist Professionals |
4.2 Prescribing Speech and Language Services |
Amber Surveski, MS, CCC-SLP |
||
4.3 Social Pragmatic Communication Training |
Kate Smidl, MS, CCC-SLP |
||
4.4 Disorders Associated with Developmental Language Disorder (DLD) |
Mary Leppert, MB BCH |
||
Level 5 |
5.1 Outcomes of Speech and Language Disorders |
Mary Leppert, MB BCH |
Medical Professionals Sub-Specialist Professionals |
Case Study |
Interactive Case Scenario |
N/A |
All Learners |
What is the KIND Curriculum?
Terms of Use & Privacy Policy
The Learning Materials are intended only to provide general information and need to be adapted for individualized patient care based on each practitioners’ professional judgment, unique patient circumstances, and other pertinent factors. The Learning Materials are not intended to constitute general medical advice or treatment or advice or treatment for any particular patient. The Learning Materials are not intended to create a doctor-patient relationship between/among Kennedy Krieger Institute, its physicians and individual patients or their family members or caregivers. Kennedy Krieger Institute makes no warranty, expressed or implied, with respect to the currency, completeness, applicability, or accuracy of the Learning Materials. To the extent that the Learning Materials include information regarding drug dosing, every effort will be made to identify when drug or medical device information included in the Learning Materials is not in agreement with FDA approval or guidance. However, it is the responsibility of the practitioner to ascertain FDA dosing recommendations and approval status of prescribed drugs and devices in their clinical practices.
The Learning Materials are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Learning Materials may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner. |